Back to Search
HEATHER KHOURY, PHARMD
PHARMD
Pharmacist
NPI: 1831752484Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
79982(CA)
Research & Publications (20)
Dasatinib treatment for Philadelphia chromosome-positive leukemias: practical considerations.
PMID 19195046·Cancer·2009
6-review
Simultaneous determination of gemcitabine and gemcitabine-squalene by liquid chromatography-tandem mass spectrometry in human plasma.
PMID 17851141·J Chromatogr B Analyt Technol Biomed Life Sci·2007
8-other
Impact of posttransplantation G-CSF on outcomes of allogeneic hematopoietic stem cell transplantation.
PMID 16239431·Blood·2006
4-observational
HGF converts ErbB2/Neu epithelial morphogenesis to cell invasion.
PMID 15548598·Mol Biol Cell·2005
7-preclinical
Correlation between karyotype and quantitative immunophenotype in acute myelogenous leukemia with t(8;21).
PMID 15181451·Mod Pathol·2004
4-observational
Multicolor karyotyping and clinicopathological analysis of three intravascular lymphoma cases.
PMID 12861069·Mod Pathol·2003
5-case
Intravascular lymphoma presenting with bone marrow involvement and leukemic phase.
PMID 12854907·Leuk Lymphoma·2003
5-case
Acute myelogenous leukemia complicated by acute necrotizing ulcerative gingivitis due to Aspergillus terreus.
PMID 12769350·Leuk Lymphoma·2003
5-case
Acute myelogenous leukemia with t(8;21)--identification of a specific immunophenotype.
PMID 14692523·Leuk Lymphoma·2003
4-observational
Low incidence of transplantation-related acute complications in patients with chronic myeloid leukemia undergoing allogeneic stem cell transplantation with a low-dose (550 cGy) total body irradiation conditioning regimen.
PMID 11464978·Biol Blood Marrow Transplant·2001
3-trial
Distinct tyrosine autophosphorylation sites mediate induction of epithelial mesenchymal like transition by an activated ErbB-2/Neu receptor.
PMID 11314013·Oncogene·2001
7-preclinical
Phase 3 study of dasatinib 140 mg once daily versus 70 mg twice daily in patients with chronic myeloid leukemia in accelerated phase resistant or intolerant to imatinib: 15-month median follow-up.
PMID 19369231·Blood·2009
3-trial
The influence of using Jordanian natural zeolite on the adsorption, physical, and mechanical properties of geopolymers products.
PMID 19036505·J Hazard Mater·2009
8-other
Metabolism evaluation of biomimetic prodrugs by in vitro models and mass spectrometry.
PMID 19467308·Int J Pharm·2009
4-observational
To G or not to G: is this still a question in allogeneic transplantation?
PMID 19279560·Bone Marrow Transplant·2009
8-other
Prior rituximab correlates with less acute graft-versus-host disease and better survival in B-cell lymphoma patients who received allogeneic peripheral blood stem cell transplantation.
PMID 19344418·Br J Haematol·2009
8-other
Dasatinib in the treatment of chronic myeloid leukemia in accelerated phase after imatinib failure: the START a trial.
PMID 19487385·J Clin Oncol·2009
3-trial
Fibroblast growth factor receptor 3 associates with and tyrosine phosphorylates p90 RSK2, leading to RSK2 activation that mediates hematopoietic transformation.
PMID 19223461·Mol Cell Biol·2009
7-preclinical
Evidence and Value: Impact on DEcisionMaking--the EVIDEM framework and potential applications.
PMID 19102752·BMC Health Serv Res·2008
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2810 S TRACY BLVD
TRACY, CA 95377 - Phone
- (209) 843-0248
Quick Facts
- NPI
- 1831752484
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile